Lipid-lowering therapy [topp]
Statins [orch, phsu]
Endothelium [tisu]
Platelets [cell]
inflammatory cells [cell]
Hyperlipidaemia [dsyn]
causality [ftcn]
Atherosclerosis [dsyn]
Statins [orch, phsu]
Drug Therapy [topp]
Cholesterol, LDL [bacs, strd]
lowering [spco]
exert [orgf]
effects [qlco]
Lipid [lipd]
lowering [spco]
Circulating [ftcn]
Released [ftcn]
Activated [acty]
Cells [cell]
Bloodstream [phsf]
Marker [clna]
vascular [bpoc]
Inflammatory cell [cell]
Activation [acty]
Disease Progression [patf]
Statins [orch, phsu]
Circulating [ftcn]
controversies [socb]
Evaluation [ftcn]
effects [qlco]
Lipid [lipd]
lowering [spco]
treatment [ftcn]
LLT [inpr]
Generation [tmco]
Patients [podg]
Primary Prevention [topp]
Atherosclerosis [dsyn]
Case-Control Study [resa]
Conduct [inbe]
Patients [podg]
Receive [qlco]
LLT [inpr]
Statins [orch, phsu]
LLT [inpr]
LLT [inpr]
N NOS [aapp, imft]
Group [idcn]
matched [resa]
Age [orga]
Gender [orga]
Cholesterol, LDL [bacs, strd]
Circulating [ftcn]
Flow Cytometry [lbpr]
Annexin V [aapp, bacs]
Cell [cell]
Specific antibody [aapp, imft]
LLT [inpr]
Patient number [inpr]
Circulating [ftcn]
P NOS [aapp, imft]
Levels [qlco]
Circulating [ftcn]
Carrying [acty]
Parental [famg]
Cell [cell]
Marker [clna]
vascular [bpoc]
Circulating [ftcn]
Cell [cell]
origin [clas]
Platelet [cell]
Endothelial cell [cell]
Pan [mamm]
Leucocyte [cell]
Specific [qlco]
Leucocyte [cell]
Subset [clas]
Blood [tisu]
LLT [inpr]
Compared [acty]
LLT [inpr]
Patients [podg]
LLT [inpr]
Patients [podg]
Reduced [qlco]
Marker [clna]
Activated [acty]
Platelets [cell]
Alpha [inpr]
beta 3 integrin [aapp, bacs]
Activated [acty]
inflammatory cells [cell]
Alpha [inpr]
M NOS [aapp, imft]
Integrin [aapp, imft, rcpt]
Tissue Factor [aapp, imft]
LLT [inpr]
CARDIOVASCULAR [bdsy]
LLT [inpr]
Patients [podg]
summary [inpr]
plasma cholesterol [lbpr]
Patients [podg]
Statin [orch, phsu]
treatment [ftcn]
Circulating [ftcn]
Carrying [acty]
Marker [clna]
Activated [acty]
Cells [cell]
findings [ftcn]
Statins [orch, phsu]
vascular [bpoc]
cell activation [celf]
